Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications (Q26796244)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Viktor A. Snezhitskiĭ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Eduard Shantsila

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Gregory Y H Lip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

1 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

943-959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Relationship between integrated backscatter and atrial fibrosis in patients with and without atrial fibrillation who are undergoing coronary bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Association between C-reactive protein and atrial fibrillation recurrence after catheter ablation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Intracellular dynamics of Smad‐mediated TGFβ signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

The origin of fibroblasts and mechanism of cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Role of miR-21 in the pathogenesis of atrial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Myocardial ultrasonic integrated backscatter analysis in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

The dynamic role of cardiac fibroblasts in development and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Galectin 3 and incident atrial fibrillation in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Left ventricular fibrosis in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Effects of persistent atrial fibrillation on serum galectin-3 levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation is associated with cardiac hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation from the pathologist's perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Risk Factors and Genetics of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

The implications of obesity for cardiac arrhythmia mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Integrated analysis of microRNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal atrial fibrillation: Role of miR-146b-5p in atrial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Role of microRNAs in cardiac remodelling: new insights and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Transforming growth factor β1-mediated atrial fibrotic activity and the recovery of atrial mechanical contraction after surgical maze procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial remodeling and atrial fibrillation: recent advances and translational perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation: the role of common and rare genetic variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

MicroRNA-34a regulates cardiac ageing and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Cardiac MRI: a central prognostic tool in myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Inflammation and the pathogenesis of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Sleep-disordered breathing and atrial fibrillation: review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Fibroblasts and myofibroblasts: what are we talking about?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Mechanisms of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Correlation between AF Substrate Ablation Difficulty and Left Atrial Fibrosis Quantified by Delayed-Enhancement Cardiac Magnetic Resonance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial extracellular matrix remodelling in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Electrical Remodeling of the Atria in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Contrasting gene expression profiles in two canine models of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Diffuse ventricular fibrosis measured by T₁ mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Origin of cardiac fibroblasts and the role of periostin

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Intramyocardial fibroblast myocyte communication

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Cardiac fibroblast: the renaissance cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Origins of cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Disruption of the myocardial extracellular matrix leads to cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Left atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: results from a prospective study of three-years follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Impact of microRNA expression in human atrial tissue in patients with atrial fibrillation undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

Periostin as a heterofunctional regulator of cardiac development and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2015.06.1313

7 January 2021

10.1016/J.JACC.2015.06.1313

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26293766%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017